ERG gene rearrangements are common in prostatic small cell carcinomas
Tamara L. Lotan(Johns Hopkins University), George J. Netto(University of Pennsylvania), Alcides Chaux(Johns Hopkins University), Charles J. Bieberich(University of Maryland, Baltimore), Wenle Wang(Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine), Michael C. Haffner(Memorial Sloan Kettering Cancer Center), Jonathan I. Epstein(Johns Hopkins University), Jessica Hicks(Johns Hopkins University), Angelo M. De Marzo(Johns Hopkins University), Antoun Toubaji(Unknown), Nilesh Gupta(Henry Ford Health System), Alan K. Meeker(Johns Hopkins University)
Cited by 219
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k